PharmaEngine, Inc. (TPEX:4162)
Taiwan · Delayed Price · Currency is TWD 62.80
-0.90 (-1.41%)
Aug 6, 2026, 9:58 AM CST
PharmaEngine Market Cap
PharmaEngine has a market cap or net worth of 9.15 billion as of August 5, 2026. Its market cap has decreased by -14.38% in one year.
Market Cap
9.15B
Enterprise Value
4.22B
Revenue
963.83M
Ranking
n/a
PE Ratio
21.74
Stock Price
62.80
ChartMarket Cap Chart
Since September 1, 2011, PharmaEngine's market cap has increased from 5.38B to 9.15B, an increase of 70.16%. That is a compound annual growth rate of 3.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 9.05B | -10.51% |
| Dec 31, 2025 | 10.11B | -22.04% |
| Dec 31, 2024 | 12.97B | -14.41% |
| Dec 29, 2023 | 15.16B | -15.60% |
| Dec 30, 2022 | 17.96B | 75.96% |
| Dec 30, 2021 | 10.21B | 21.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ACRO Biomedical | 11.93B |
| Tanvex BioPharma | 9.88B |
| TCM Biotech International | 9.74B |
| Polaris Group | 9.33B |
| Gongwin Biopharm Holdings | 9.21B |
| AP Biosciences | 8.46B |
| Locus Cell | 7.54B |
| Acepodia | 6.99B |